A citation-based method for searching scientific literature


List of co-cited articles
238 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Lei Tian, Jie Gao, Jianqiang Hao, Yu Zhang, Huimin Yi, Timothy D O'Brien, Robert Sorenson, Jian Luo, Zhiguang Guo. Endocrinology 2010
87
44

Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.
S L Ellis, E G Moser, J K Snell-Bergeon, A S Rodionova, R M Hazenfield, S K Garg. Diabet Med 2011
89
40



The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, Michael Mark, Thomas Klein. J Endocrinol 2012
38
36

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
J Andrew Pospisilik, Jennifer Martin, Timothy Doty, Jan A Ehses, Nathalie Pamir, Francis C Lynn, Shalea Piteau, Hans-Ulrich Demuth, Christopher H S McIntosh, Raymond A Pederson. Diabetes 2003
273
32

Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
74
32

Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes.
Hun Sik Kim, Myoung Sook Han, Kun Wook Chung, Sunshin Kim, Eunshil Kim, Myoung Joo Kim, Eunkyeong Jang, Hyun Ah Lee, Jeehee Youn, Shizuo Akira,[...]. Immunity 2007
166
24

Inhibition of autoimmune diabetes by TLR2 tolerance.
Do-Hoon Kim, June-Chul Lee, Sunshin Kim, Seung Hoon Oh, Moon-Kyu Lee, Kwang-Won Kim, Myung-Shik Lee. J Immunol 2011
46
24

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Satish K Garg, Emily G Moser, Bruce W Bode, Leslie J Klaff, William R Hiatt, Christie Beatson, Janet K Snell-Bergeon. Endocr Pract 2013
68
24

C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study.
Odd Erik Johansen, Bernhard O Boehm, Valdemar Grill, Peter A Torjesen, Sudipta Bhattacharya, Sanjay Patel, Kristiane Wetzel, Hans-Juergen Woerle. Diabetes Care 2014
41
24

A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
Jae Min Cho, Hye Won Jang, Hwanju Cheon, Yeon Taek Jeong, Do-Hoon Kim, Yu-Mi Lim, Song-Hyen Choi, Eun-Kyoung Yang, Chang-Yell Shin, Moon Ho Son,[...]. Diabetes Res Clin Pract 2011
40
20

Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
Li Wen, Ruth E Ley, Pavel Yu Volchkov, Peter B Stranges, Lia Avanesyan, Austin C Stonebraker, Changyun Hu, F Susan Wong, Gregory L Szot, Jeffrey A Bluestone,[...]. Nature 2008
20

Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes.
Julien Diana, Yannick Simoni, Laetitia Furio, Lucie Beaudoin, Birgitta Agerberth, Franck Barrat, Agnès Lehuen. Nat Med 2013
275
20

Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
61
20

TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
Yiqun Zhang, Andrew S Lee, Afshin Shameli, Xuan Geng, Diane Finegood, Pere Santamaria, Jan P Dutz. J Immunol 2010
56
16

Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes.
Subha Karumuthil-Melethil, Nicolas Perez, Ruobing Li, Chenthamarakshan Vasu. J Immunol 2008
66
16

Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies.
Zuoan Yi, Ramiro Diz, Aaron J Martin, Yves Maurice Morillon, Douglas E Kline, Li Li, Bo Wang, Roland Tisch. Diabetes 2012
21
19

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.
D Elias, T Reshef, O S Birk, R van der Zee, M D Walker, I R Cohen. Proc Natl Acad Sci U S A 1991
374
16

The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice.
F Susan Wong, Changyun Hu, Li Zhang, Wei Du, Lena Alexopoulou, Richard A Flavell, Li Wen. Ann N Y Acad Sci 2008
55
16

NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice.
Sunshin Kim, Isabelle Millet, Hun Sik Kim, Ja Young Kim, Myoung Sook Han, Moon-Kyu Lee, Kwang-Won Kim, Robert S Sherwin, Michael Karin, Myung-Shik Lee. Proc Natl Acad Sci U S A 2007
98
16

Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.
Wilma L Suarez-Pinzon, Robert F Power, Yanhua Yan, Clive Wasserfall, Mark Atkinson, Alex Rabinovitch. Diabetes 2008
132
16

Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?
J D Trudeau, J P Dutz, E Arany, D J Hill, W E Fieldus, D T Finegood. Diabetes 2000
218
16

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
James Mu, John Woods, Yun-Ping Zhou, Ranabir Sinha Roy, Zhihua Li, Emanuel Zycband, Yue Feng, Lan Zhu, Cai Li, Andrew D Howard,[...]. Diabetes 2006
355
16

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling.
Haitao Wen, Denis Gris, Yu Lei, Sushmita Jha, Lu Zhang, Max Tze-Han Huang, Willie June Brickey, Jenny P-Y Ting. Nat Immunol 2011
16

Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
D T Finegood, M D McArthur, D Kojwang, M J Thomas, B G Topp, T Leonard, R E Buckingham. Diabetes 2001
295
16

Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model.
Shannon Turley, Laurent Poirot, Masakazu Hattori, Christophe Benoist, Diane Mathis. J Exp Med 2003
261
16

Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26).
Bertram Bengsch, Bianca Seigel, Tobias Flecken, Julia Wolanski, Hubert E Blum, Robert Thimme. J Immunol 2012
104
16


Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.
Zubair Shah, Thomas Kampfrath, Jeffrey A Deiuliis, Jixin Zhong, Colleen Pineda, Zhekang Ying, Xiaohua Xu, Bo Lu, Susan Moffatt-Bruce, Rekha Durairaj,[...]. Circulation 2011
268
16



Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
16

Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
Zhiguang Zhou, Yufei Xiang, Linong Ji, Weiping Jia, Guang Ning, Gan Huang, Lin Yang, Jian Lin, Zhenqi Liu, William A Hagopian,[...]. Diabetes 2013
140
16

Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children.
Natalia Marek-Trzonkowska, Malgorzata Mysliwiec, Anita Dobyszuk, Marcelina Grabowska, Ilona Techmanska, Jolanta Juscinska, Magdalena A Wujtewicz, Piotr Witkowski, Wojciech Mlynarski, Anna Balcerska,[...]. Diabetes Care 2012
273
12

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.
S Baekkeskov, H J Aanstoot, S Christgau, A Reetz, M Solimena, M Cascalho, F Folli, H Richter-Olesen, P De Camilli. Nature 1990
12

IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice.
Ningwen Tai, Hisafumi Yasuda, Yufei Xiang, Li Zhang, Daniel Rodriguez-Pinto, Koichi Yokono, Robert Sherwin, F Susan Wong, Masao Nagata, Li Wen. Clin Immunol 2011
43
12

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Carlos E B Couri, Maria C B Oliveira, Ana B P L Stracieri, Daniela A Moraes, Fabiano Pieroni, George M N Barros, Maria Isabel A Madeira, Kelen C R Malmegrim, Maria C Foss-Freitas, Belinda P Simões,[...]. JAMA 2009
269
12

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
Mériam Belghith, Jeffrey A Bluestone, Samia Barriot, Jérôme Mégret, Jean-François Bach, Lucienne Chatenoud. Nat Med 2003
481
12

Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Dirk Reinhold, Alexander Goihl, Sabine Wrenger, Annegret Reinhold, Ulrike C Kühlmann, Jürgen Faust, Klaus Neubert, Anja Thielitz, Stefan Brocke, Michael Täger,[...]. Clin Chem Lab Med 2009
54
12

Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
Nicole A Sherry, Wei Chen, Jake A Kushner, Mariela Glandt, Qizhi Tang, Sue Tsai, Pere Santamaria, Jeffrey A Bluestone, Anne-Marie B Brillantes, Kevan C Herold. Endocrinology 2007
139
12

Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation.
Vitaly Ablamunits, Octavian Henegariu, Jakob Bondo Hansen, Lynn Opare-Addo, Paula Preston-Hurlburt, Pere Santamaria, Thomas Mandrup-Poulsen, Kevan C Herold. Diabetes 2012
88
12

Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.
Kalpit A Vora, Gene Porter, Roche Peng, Yan Cui, Kellyann Pryor, George Eiermann, Dennis M Zaller. BMC Immunol 2009
39
12

The inflammasomes.
Kate Schroder, Jurg Tschopp. Cell 2010
12

NLR functions beyond pathogen recognition.
Thomas A Kufer, Philippe J Sansonetti. Nat Immunol 2011
136
12

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.
Hye-Mi Lee, Jwa-Jin Kim, Hyun Jin Kim, Minho Shong, Bon Jeong Ku, Eun-Kyeong Jo. Diabetes 2013
408
12

Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
Claus M Larsen, Mirjam Faulenbach, Allan Vaag, Aage Vølund, Jan A Ehses, Burkhardt Seifert, Thomas Mandrup-Poulsen, Marc Y Donath. N Engl J Med 2007
12

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.
Bolormaa Vandanmagsar, Yun-Hee Youm, Anthony Ravussin, Jose E Galgani, Krisztian Stadler, Randall L Mynatt, Eric Ravussin, Jacqueline M Stephens, Vishwa Deep Dixit. Nat Med 2011
12

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.
Seth L Masters, Aisling Dunne, Shoba L Subramanian, Rebecca L Hull, Gillian M Tannahill, Fiona A Sharp, Christine Becker, Luigi Franchi, Eiji Yoshihara, Zhe Chen,[...]. Nat Immunol 2010
849
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.